LCTX icon

Lineage Cell Therapeutics

115 hedge funds and large institutions have $152M invested in Lineage Cell Therapeutics in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-2
Holders Change %
-1.71%
% of All Funds
2.64%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
9
Increased
36
Reduced
31
Closed
11
Calls
$349K
Puts
$139K
Net Calls
+$210K
Net Calls Change
+$210K
Name Holding Trade Value Shares
Change
Shares
Change %
CHP
101
Cable Hill Partners
Oregon
$12K +$9.6K +4,572 +400%
AG
102
Advisor Group
Arizona
$9K -$2.77K -1,143 -24%
FDCDDQ
103
Federation des caisses Desjardins du Quebec
Quebec, Canada
$8.07K
Royal Bank of Canada
104
Royal Bank of Canada
Ontario, Canada
$7K +$6.41K +2,749 +1,078%
RFA
105
Reilly Financial Advisors
California
$5K
TWA
106
TCI Wealth Advisors
Arizona
$3K
PCM
107
Poehling Capital Management
Wisconsin
$3K
AIS
108
Accurate Investment Solutions
Pennsylvania
$3K +$3K +1,143 New
SPIA
109
Steward Partners Investment Advisory
New York
$2K
VIA
110
Vantage Investment Advisors
Pennsylvania
$1K
PK
111
Pflug Koory
Nebraska
$1K
AG
112
Artal Group
Luxembourg
-$3.35M -1,779,708 Closed
GCP
113
GSA Capital Partners
United Kingdom
-$359K -190,671 Closed
V
114
Veritable
Delaware
-$233K -124,124 Closed
VF
115
Virtu Financial
New York
-$225K -119,836 Closed
Connor, Clark & Lunn Investment Management (CC&L)
116
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$210K -111,510 Closed
Jane Street
117
Jane Street
New York
-$84K -44,567 Closed
Parallax Volatility Advisers
118
Parallax Volatility Advisers
California
-$26K -13,778 Closed
TRCT
119
Tower Research Capital (TRC)
New York
-$12K -6,274 Closed
Macquarie Group
120
Macquarie Group
Australia
-$8K -4,343 Closed
Group One Trading
121
Group One Trading
Illinois
-$4K -2,341 Closed